130 related articles for article (PubMed ID: 12513914)
21. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.
Yarchoan R; Pluda JM; Wyvill KM; Aleman K; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Little RF
Crit Rev Immunol; 2007; 27(5):401-14. PubMed ID: 18197804
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
Uldrick TS; Wyvill KM; Kumar P; O'Mahony D; Bernstein W; Aleman K; Polizzotto MN; Steinberg SM; Pittaluga S; Marshall V; Whitby D; Little RF; Yarchoan R
J Clin Oncol; 2012 May; 30(13):1476-83. PubMed ID: 22430271
[TBL] [Abstract][Full Text] [Related]
23. Disseminated Kaposi's sarcoma in patients with HIV infection correlates to high serum levels of IL-10.
Machado PR; Farias KJ; Genre J; Oliveira CJ; Guedes PM; da Fonseca BA
Viral Immunol; 2014 Sep; 27(7):356-60. PubMed ID: 25026101
[TBL] [Abstract][Full Text] [Related]
24. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
Baumann R; Täuber MG; Opravil M; Hirschel B; Kinloch S; Chave JP; Pletscher M; Lüthy R
Klin Wochenschr; 1991 May; 69(8):360-7. PubMed ID: 1909399
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
Cianfrocca M; Cooley TP; Lee JY; Rudek MA; Scadden DT; Ratner L; Pluda JM; Figg WD; Krown SE; Dezube BJ
J Clin Oncol; 2002 Jan; 20(1):153-9. PubMed ID: 11773164
[TBL] [Abstract][Full Text] [Related]
26. Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.
Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Peer CJ; Bevans M; Sereti I; Maldarelli F; Whitby D; Marshall V; Goncalves PH; Khetani V; Figg WD; Steinberg SM; Zeldis JB; Yarchoan R
J Clin Oncol; 2016 Dec; 34(34):4125-4131. PubMed ID: 27863194
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
Welles L; Saville MW; Lietzau J; Pluda JM; Wyvill KM; Feuerstein I; Figg WD; Lush R; Odom J; Wilson WH; Fajardo MT; Humphrey RW; Feigal E; Tuck D; Steinberg SM; Broder S; Yarchoan R
J Clin Oncol; 1998 Mar; 16(3):1112-21. PubMed ID: 9508198
[TBL] [Abstract][Full Text] [Related]
28. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
[TBL] [Abstract][Full Text] [Related]
29. Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide.
Solèr RA; Howard M; Brink NS; Gibb D; Tedder RS; Nadal D
Clin Infect Dis; 1996 Sep; 23(3):501-3; discussion 504-5. PubMed ID: 8879772
[TBL] [Abstract][Full Text] [Related]
30. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.
Marcelin AG; Gorin I; Morand P; Ait-Arkoub Z; Deleuze J; Morini JP; Calvez V; Dupin N
AIDS Res Hum Retroviruses; 2004 Jul; 20(7):704-8. PubMed ID: 15307914
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
32. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.
Husain SR; Puri RK
Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro.
Huang YQ; Li JJ; Kim KS; Nicolaides A; Zhang WG; Le J; Poiesz BJ; Friedman-Kien AE
AIDS; 1993 Mar; 7(3):317-22. PubMed ID: 8471192
[TBL] [Abstract][Full Text] [Related]
35. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
[TBL] [Abstract][Full Text] [Related]
37. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
38. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
[TBL] [Abstract][Full Text] [Related]
39. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
40. Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion.
Klimas N; Patarca R; Walling J; Garcia R; Mayer V; Moody D; Okarma T; Fletcher MA
AIDS; 1994 Aug; 8(8):1073-81. PubMed ID: 7986402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
